Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy

[1]  C. Jakubzick,et al.  CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes , 2023, The Journal of experimental medicine.

[2]  Jing Zhang,et al.  Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma , 2023, International journal of molecular sciences.

[3]  David Chisanga,et al.  MYB orchestrates T cell exhaustion and response to checkpoint inhibition , 2022 .

[4]  V. Buchholz,et al.  MYB orchestrates T cell exhaustion and response to checkpoint inhibition , 2022, Nature.

[5]  Nikhil S. Joshi,et al.  A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response , 2021, Science Immunology.

[6]  Feng Sun,et al.  CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid‐derived suppressor cells , 2021, Immunity, inflammation and disease.

[7]  D. Busch,et al.  Fate mapping of single NK cells identifies a type 1 innate lymphoid-like lineage that bridges innate and adaptive recognition of viral infection , 2021, Immunity.

[8]  N. Halama,et al.  T cells armed with the C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours , 2021, Nature Biomedical Engineering.

[9]  Lei Cao,et al.  Enhance anti-lung tumor efficacy of chimeric antigen receptor-T cells by ectopic expression of C-C motif chemokine receptor 6. , 2021, Science bulletin.

[10]  V. Buchholz,et al.  Early emergence of T central memory precursors programs clonal dominance during chronic viral infection , 2020, Nature Immunology.

[11]  David Chisanga,et al.  Early precursor T cells establish and propagate T cell exhaustion in chronic infection , 2020, Nature Immunology.

[12]  K. Izumi,et al.  The CCL20-CCR6 Axis in Cancer Progression , 2020, International journal of molecular sciences.

[13]  Christian Stemberger,et al.  Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function , 2019, Nature Biomedical Engineering.

[14]  Jennifer D. Oduro,et al.  Distinct Surface Expression of Activating Receptor Ly49H Drives Differential Expansion of NK Cell Clones upon Murine Cytomegalovirus Infection. , 2019, Immunity.

[15]  Dennie T. Frederick,et al.  Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy. , 2019, Immunity.

[16]  U. V. von Andrian,et al.  CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes , 2019, The Journal of experimental medicine.

[17]  W. Gong,et al.  Chemokines in homeostasis and diseases , 2018, Cellular & Molecular Immunology.

[18]  Weiping Zou,et al.  Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy , 2017, Nature Reviews Immunology.

[19]  Mithat Gönen,et al.  Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection , 2017, Nature.

[20]  Atique U. Ahmed,et al.  CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. , 2016, Cancer research.

[21]  Matheus C. Bürger,et al.  Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy , 2016, Nature.

[22]  P. Allavena,et al.  Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient , 2016, Journal of Immunotherapy for Cancer.

[23]  S. Ormanns,et al.  C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer , 2015, Oncoimmunology.

[24]  V. Hornung,et al.  Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression. , 2015, Cancer research.

[25]  K. Mertz,et al.  Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis , 2014, Nature.

[26]  R. Ahmed,et al.  Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection , 2014, The Journal of experimental medicine.

[27]  A. Cerwenka,et al.  Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth , 2012, The Journal of Immunology.

[28]  U. V. von Andrian,et al.  CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. , 2012, Immunity.

[29]  W. Fang,et al.  CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms* , 2012, The Journal of Biological Chemistry.

[30]  Lin Zhang,et al.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells , 2011, Nature.

[31]  C. June,et al.  Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor , 2011, Clinical Cancer Research.

[32]  C. Liu,et al.  Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses , 2010, Clinical Cancer Research.

[33]  T. Okazaki,et al.  PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo1 , 2009, The Journal of Immunology.

[34]  M. Tretiakova,et al.  Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. , 2009, Cancer research.

[35]  Simon C Watkins,et al.  Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10. , 2009, Cancer research.

[36]  B. Hinz,et al.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells , 2007, Nature Immunology.

[37]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[38]  Michelle L. Varney,et al.  IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 , 2003, The Journal of Immunology.

[39]  C. Melief,et al.  Cancer immunology. , 2011, Current opinion in immunology.

[40]  H. Friess,et al.  Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. , 2008, International journal of oncology.